Status:
COMPLETED
Pulmonary Diffusing Capacity During Incremental Exercise in COPD
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
COPD
Healthy
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Background: The combined measurement of pulmonary diffusing capacity for carbon monoxide (CO) and nitric oxide (NO) (DL,CO,NO) has recently been standardized and validated for clinical use. It involv...
Detailed Description
Introduction and background A pattern that applies to the majority of the more than 250 million people who suffer from chronic obstructive pulmonary disease (COPD) worldwide, is a downward spiral of e...
Eligibility Criteria
Inclusion
- Inclusion criteria for COPD patients
- Men and women
- 40-80 years
- Mild to severe COPD (GOLD stage I to IIII)
- Inclusion criteria for healthy participants
- Men and women
- Age +/- 3 years of an included COPD patient
- Exclusion criteria for COPD patients
- Known ischaemic heart disease
- Known heart failure
- Cardiac arrythmias
- Dementia or other severe neurological disease
- Known vascular ischaemic disease
- Symptoms of infection (bacterial/viral) within 2 weeks prior to the study
- Pregnancy
- Exclusion criteria for heathy controls
- COPD
- Known ischaemic heart disease
- Known heart failure
- Cardiac arrythmias
- Dementia or other severe neurological disease
- Known vascular ischaemic disease
- Symptoms of infection (bacterial/viral) within 2 weeks prior to the study
- Pregnancy
Exclusion
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06505902
Start Date
July 15 2024
End Date
February 1 2025
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Aktiv Sundhed (CFAS), Rigshospitalet, Copenhagen, Denmark.
Copenhagen, København Ø, Denmark, 2100